Celltrion taps Lonza to produce some of its Remicade biosimilar

Celltrion taps Lonza to produce some of its Remicade biosimilar

Source: 
Biopharma Dive
snippet: 

Under the deal, Lonza will make Remsima drug substance at its commercial facility in Singapore to cover European and North American markets.